Talk:Semaglutide
{{Talkheader}}
{{Reliable sources for medical articles}}
{{WikiProject banner shell|class=B|
{{WikiProject Pharmacology|importance=Mid}}
{{WikiProject Medicine |importance=Mid}}
{{WikiProject Chemicals|importance=Low}}
{{WikiProject Popular Culture|importance=|}}
}}
{{User:MiszaBot/config
| algo = old(360d)
| archive = Talk:Semaglutide/Archive %(counter)d
| counter = 1
| maxarchivesize = 125K
| archiveheader = {{Archive}}
| minthreadstoarchive = 1
| minthreadsleft = 5
}}
NYT article on using the drug for diabetes prevention
This is a respected secondary source discussing one study, so evaluate accordingly as per WP:MEDRS.
- {{cite web |last=Blum |first=Dani |title=Ozempic Could Prevent Diabetes. Should We Use It For That? |website=The New York Times |date=2024-11-13 |url=https://www.nytimes.com/2024/11/13/well/ozempic-prediabetes.html |access-date=2024-11-16}}
Renal Benefits
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial - https://doi.org/10.1038/s41591-024-03133-0
Semaglutide seems to show some renal improvement with or without SGLT2 inhibitors in patients with ckd and T2DM. May be useful to add a section on renal protective effects. I'll defer to the community 12.50.9.2 (talk) 19:55, 16 December 2024 (UTC)